Demographic and clinical characteristics of the study population (N = 112).

Note: HAART: highly active antiretroviral therapy. IQR: interquartile range. CD4+ lymphocyte count nadir: the lowest CD4+ lymphocyte count while in care. ADE: AIDS-defining event. IDU: history of injection drug use as a risk factor for HIV infection acquisition. HCV: hepatitis C virologic status prior to first HAART initiation. NA: not available. ART: antiretroviral therapy. PI: protease inhibitor. NNRTI: non-nucleoside reverse transcriptase inhibitor.*The reference group.aContinuous data were compared by Kruskal-Wallis test. Categorical data were compared by 2-sided Fisher's exact test.